Search

Ilia I. Ouspenski

Examiner (ID: 1237)

Most Active Art Unit
1644
Art Unit(s)
1644
Total Applications
1566
Issued Applications
1023
Pending Applications
156
Abandoned Applications
432

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 7061059 [patent_doc_number] => 20050003420 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Recycled mutagenesis of restriction endonuclease toward enhanced catalytic activity' [patent_app_type] => utility [patent_app_number] => 10/874527 [patent_app_country] => US [patent_app_date] => 2004-06-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 9551 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0003/20050003420.pdf [firstpage_image] =>[orig_patent_app_number] => 10874527 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/874527
Recycled mutagenesis of restriction endonuclease toward enhanced catalytic activity Jun 22, 2004 Abandoned
Array ( [id] => 7192994 [patent_doc_number] => 20050163772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-07-28 [patent_title] => 'B7S1: an immune modulator' [patent_app_type] => utility [patent_app_number] => 10/871696 [patent_app_country] => US [patent_app_date] => 2004-06-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 21706 [patent_no_of_claims] => 54 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0163/20050163772.pdf [firstpage_image] =>[orig_patent_app_number] => 10871696 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/871696
B7S1: an immune modulator Jun 15, 2004 Abandoned
Array ( [id] => 348666 [patent_doc_number] => 07494779 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-02-24 [patent_title] => 'Method for producing human antibodies to human CD152 with properties of agonist, antagonist, or inverse agonist' [patent_app_type] => utility [patent_app_number] => 10/866120 [patent_app_country] => US [patent_app_date] => 2004-06-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 6045 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 282 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/494/07494779.pdf [firstpage_image] =>[orig_patent_app_number] => 10866120 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/866120
Method for producing human antibodies to human CD152 with properties of agonist, antagonist, or inverse agonist Jun 13, 2004 Issued
Array ( [id] => 562255 [patent_doc_number] => 07465446 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-12-16 [patent_title] => 'Surrogate therapeutic endpoint for anti-CTLA4-based immunotherapy of disease' [patent_app_type] => utility [patent_app_number] => 10/857749 [patent_app_country] => US [patent_app_date] => 2004-05-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 11850 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 37 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/465/07465446.pdf [firstpage_image] =>[orig_patent_app_number] => 10857749 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/857749
Surrogate therapeutic endpoint for anti-CTLA4-based immunotherapy of disease May 26, 2004 Issued
Array ( [id] => 195512 [patent_doc_number] => 07635472 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-12-22 [patent_title] => 'Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders' [patent_app_type] => utility [patent_app_number] => 10/554852 [patent_app_country] => US [patent_app_date] => 2004-05-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 17 [patent_no_of_words] => 15809 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 71 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/635/07635472.pdf [firstpage_image] =>[orig_patent_app_number] => 10554852 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/554852
Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders May 25, 2004 Issued
Array ( [id] => 7082689 [patent_doc_number] => 20050048069 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-03-03 [patent_title] => 'Methods and compositions for modulating immunity' [patent_app_type] => utility [patent_app_number] => 10/850562 [patent_app_country] => US [patent_app_date] => 2004-05-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 41 [patent_figures_cnt] => 41 [patent_no_of_words] => 46143 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0048/20050048069.pdf [firstpage_image] =>[orig_patent_app_number] => 10850562 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/850562
Methods of treating allergy by administering a CD200 protein May 20, 2004 Issued
Array ( [id] => 7060575 [patent_doc_number] => 20050002935 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Use of B7-H3 as an immunoregulatory agent' [patent_app_type] => utility [patent_app_number] => 10/824481 [patent_app_country] => US [patent_app_date] => 2004-04-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 8 [patent_figures_cnt] => 8 [patent_no_of_words] => 16466 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20050002935.pdf [firstpage_image] =>[orig_patent_app_number] => 10824481 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/824481
Use of B7-H3 as an immunoregulatory agent Apr 14, 2004 Abandoned
Array ( [id] => 7677670 [patent_doc_number] => 20040152156 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Regulation of human b7-h2 protein' [patent_app_type] => new [patent_app_number] => 10/250533 [patent_app_country] => US [patent_app_date] => 2004-04-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 22 [patent_figures_cnt] => 22 [patent_no_of_words] => 21821 [patent_no_of_claims] => 51 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 31 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0152/20040152156.pdf [firstpage_image] =>[orig_patent_app_number] => 10250533 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/250533
Regulation of human b7-h2 protein Apr 8, 2004 Abandoned
Array ( [id] => 5254165 [patent_doc_number] => 20070135621 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-14 [patent_title] => 'Therapeutic products with enhance ability to immunomodulate cell functions' [patent_app_type] => utility [patent_app_number] => 10/551819 [patent_app_country] => US [patent_app_date] => 2004-04-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 11878 [patent_no_of_claims] => 55 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0135/20070135621.pdf [firstpage_image] =>[orig_patent_app_number] => 10551819 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/551819
Preparation of human, humanized or chimaeric antibodies or polypeptides having different binding profiles to Fcgamma receptors Apr 4, 2004 Issued
Array ( [id] => 7428478 [patent_doc_number] => 20040161814 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-19 [patent_title] => 'Kinase Capable of site-specific phosphorylation of IkappaBalpha' [patent_app_type] => new [patent_app_number] => 10/810793 [patent_app_country] => US [patent_app_date] => 2004-03-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 32 [patent_figures_cnt] => 32 [patent_no_of_words] => 36582 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0161/20040161814.pdf [firstpage_image] =>[orig_patent_app_number] => 10810793 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/810793
Antibody to a kinase capable of site-specific phosphorylation of IκBα Mar 25, 2004 Issued
Array ( [id] => 7060556 [patent_doc_number] => 20050002916 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-01-06 [patent_title] => 'Cytokine-expressing cellular vaccine combinations' [patent_app_type] => utility [patent_app_number] => 10/807449 [patent_app_country] => US [patent_app_date] => 2004-03-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 23048 [patent_no_of_claims] => 43 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0002/20050002916.pdf [firstpage_image] =>[orig_patent_app_number] => 10807449 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/807449
Cytokine-expressing cellular vaccine combinations Mar 23, 2004 Abandoned
Array ( [id] => 7264671 [patent_doc_number] => 20040151669 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-05 [patent_title] => 'Cell surface molecule mediating cell adhesion and signal transmission' [patent_app_type] => new [patent_app_number] => 10/798195 [patent_app_country] => US [patent_app_date] => 2004-03-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 31659 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 67 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0151/20040151669.pdf [firstpage_image] =>[orig_patent_app_number] => 10798195 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/798195
Cell surface molecule mediating cell adhesion and signal transmission Mar 10, 2004 Abandoned
Array ( [id] => 7287059 [patent_doc_number] => 20040146991 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-29 [patent_title] => 'Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof' [patent_app_type] => new [patent_app_number] => 10/800250 [patent_app_country] => US [patent_app_date] => 2004-03-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 78 [patent_figures_cnt] => 78 [patent_no_of_words] => 49031 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 99 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0146/20040146991.pdf [firstpage_image] =>[orig_patent_app_number] => 10800250 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/800250
Human monoclonal antibody against a costimulatory signal transduction molecule AILIM and pharmaceutical use thereof Mar 9, 2004 Abandoned
Array ( [id] => 7169910 [patent_doc_number] => 20050202522 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-15 [patent_title] => 'Method of screening for antimicrobial agents' [patent_app_type] => utility [patent_app_number] => 10/793746 [patent_app_country] => US [patent_app_date] => 2004-03-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 58896 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0202/20050202522.pdf [firstpage_image] =>[orig_patent_app_number] => 10793746 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/793746
Method of screening for antimicrobial agents Mar 7, 2004 Abandoned
Array ( [id] => 439471 [patent_doc_number] => 07259147 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2007-08-21 [patent_title] => 'Methods of treating multiple sclerosis with a JTT-1 polypeptide' [patent_app_type] => utility [patent_app_number] => 10/794344 [patent_app_country] => US [patent_app_date] => 2004-03-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 39 [patent_no_of_words] => 31472 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 117 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/259/07259147.pdf [firstpage_image] =>[orig_patent_app_number] => 10794344 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/794344
Methods of treating multiple sclerosis with a JTT-1 polypeptide Mar 4, 2004 Issued
Array ( [id] => 7326879 [patent_doc_number] => 20040253229 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-16 [patent_title] => 'Graft rejection suppressors' [patent_app_type] => new [patent_app_number] => 10/793171 [patent_app_country] => US [patent_app_date] => 2004-03-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 14074 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0253/20040253229.pdf [firstpage_image] =>[orig_patent_app_number] => 10793171 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/793171
Methods of suppressing, treating, or preventing graft rejection with an antibody or a portion thereof that binds to AILIM Mar 3, 2004 Issued
Array ( [id] => 7319174 [patent_doc_number] => 20040224962 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-11-11 [patent_title] => 'Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss' [patent_app_type] => new [patent_app_number] => 10/791984 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 15338 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 76 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0224/20040224962.pdf [firstpage_image] =>[orig_patent_app_number] => 10791984 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/791984
Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss Mar 2, 2004 Abandoned
Array ( [id] => 7234321 [patent_doc_number] => 20040157296 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Canine and feline B7-2 proteins, compositions and uses thereof' [patent_app_type] => new [patent_app_number] => 10/790396 [patent_app_country] => US [patent_app_date] => 2004-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 29894 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 22 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157296.pdf [firstpage_image] =>[orig_patent_app_number] => 10790396 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/790396
Canine and feline B7-2 proteins, compositions and uses thereof Feb 29, 2004 Issued
Array ( [id] => 252803 [patent_doc_number] => 07579437 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2009-08-25 [patent_title] => 'Polypeptides and methods for making the same' [patent_app_type] => utility [patent_app_number] => 10/547364 [patent_app_country] => US [patent_app_date] => 2004-02-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 5187 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 4 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/579/07579437.pdf [firstpage_image] =>[orig_patent_app_number] => 10547364 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/547364
Polypeptides and methods for making the same Feb 26, 2004 Issued
Array ( [id] => 5022196 [patent_doc_number] => 20070148162 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2007-06-28 [patent_title] => 'Molecule which binds cd80 and cd86' [patent_app_type] => utility [patent_app_number] => 10/546727 [patent_app_country] => US [patent_app_date] => 2004-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 7621 [patent_no_of_claims] => 10 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0148/20070148162.pdf [firstpage_image] =>[orig_patent_app_number] => 10546727 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/546727
Molecule which binds cd80 and cd86 Feb 25, 2004 Abandoned
Menu